State Cancer Profiles

Interpretation of Incidence Rates Data

Incidence Rate Report by State

Melanoma of the Skin (Late Stage^), 2018-2022

All Races (includes Hispanic), Both Sexes, All Ages

Sorted by CI*Rank

Explanation of Column Headers
Incidence Rate (95% Confidence Interval) - The incidence rate is based upon 100,000 people and is an annual rate (or average annual rate) based on the time period indicated. Rates are age-adjusted by 5-year age groups to the 2000 U.S. standard million population.

Percent of Cases with Late Stage - This is the number of late stages cases compared to the number of cases for all stages.

Other Notes

• Larger confidence intervals indicate less stability of the data. This is often due to low counts that are not quite low enough to be suppressed.
• Data is currently being suppressed if there are fewer than 16 counts for the time period.

Line by Line Interpretation of the Report

US (SEER+NPCR)¹

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.3 to 3.3 and 13,082 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A

Utah⁷

• Rate : The incidence rate is 4.8 with a 95% confidence interval from 4.4 to 5.2 and 141 average annual cases over 2018-2022.
• CI*Rank ⋔ : 1 (1, 6)
• Percent of Cases with Late Stage :

West Virginia²

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.0 to 4.8 and 104 average annual cases over 2018-2022.
• CI*Rank ⋔ : 2 (1, 18)
• Percent of Cases with Late Stage :

Indiana²

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 4.2 to 4.6 and 342 average annual cases over 2018-2022.
• CI*Rank ⋔ : 3 (1, 11)
• Percent of Cases with Late Stage :

New Hampshire²

• Rate : The incidence rate is 4.4 with a 95% confidence interval from 3.9 to 4.8 and 80 average annual cases over 2018-2022.
• CI*Rank ⋔ : 4 (1, 20)
• Percent of Cases with Late Stage :

Ohio²

• Rate : The incidence rate is 4.2 with a 95% confidence interval from 4.1 to 4.4 and 608 average annual cases over 2018-2022.
• CI*Rank ⋔ : 5 (2, 13)
• Percent of Cases with Late Stage :

Vermont²

• Rate : The incidence rate is 4.2 with a 95% confidence interval from 3.6 to 4.9 and 36 average annual cases over 2018-2022.
• CI*Rank ⋔ : 6 (1, 33)
• Percent of Cases with Late Stage :

Kentucky⁷

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.9 to 4.4 and 219 average annual cases over 2018-2022.
• CI*Rank ⋔ : 7 (2, 18)
• Percent of Cases with Late Stage :

South Dakota²

• Rate : The incidence rate is 4.1 with a 95% confidence interval from 3.5 to 4.7 and 41 average annual cases over 2018-2022.
• CI*Rank ⋔ : 8 (1, 34)
• Percent of Cases with Late Stage :

Delaware²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.5 to 4.6 and 51 average annual cases over 2018-2022.
• CI*Rank ⋔ : 9 (1, 33)
• Percent of Cases with Late Stage :

Montana²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.5 to 4.5 and 54 average annual cases over 2018-2022.
• CI*Rank ⋔ : 10 (1, 32)
• Percent of Cases with Late Stage :

Wisconsin²

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.8 to 4.2 and 290 average annual cases over 2018-2022.
• CI*Rank ⋔ : 11 (4, 22)
• Percent of Cases with Late Stage :

Iowa⁷

• Rate : The incidence rate is 4.0 with a 95% confidence interval from 3.7 to 4.3 and 153 average annual cases over 2018-2022.
• CI*Rank ⋔ : 12 (3, 25)
• Percent of Cases with Late Stage :

Tennessee²

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.7 to 4.1 and 319 average annual cases over 2018-2022.
• CI*Rank ⋔ : 13 (5, 23)
• Percent of Cases with Late Stage :

Florida²

• Rate : The incidence rate is 3.9 with a 95% confidence interval from 3.8 to 4.0 and 1,183 average annual cases over 2018-2022.
• CI*Rank ⋔ : 14 (8, 20)
• Percent of Cases with Late Stage :

Idaho⁷

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.5 to 4.2 and 81 average annual cases over 2018-2022.
• CI*Rank ⋔ : 15 (3, 32)
• Percent of Cases with Late Stage :

Maine²

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.4 to 4.3 and 73 average annual cases over 2018-2022.
• CI*Rank ⋔ : 16 (3, 35)
• Percent of Cases with Late Stage :

North Dakota²

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.2 to 4.5 and 33 average annual cases over 2018-2022.
• CI*Rank ⋔ : 17 (1, 41)
• Percent of Cases with Late Stage :

Oklahoma²

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.5 to 4.1 and 170 average annual cases over 2018-2022.
• CI*Rank ⋔ : 18 (7, 29)
• Percent of Cases with Late Stage :

Wyoming²

• Rate : The incidence rate is 3.8 with a 95% confidence interval from 3.1 to 4.5 and 26 average annual cases over 2018-2022.
• CI*Rank ⋔ : 19 (1, 44)
• Percent of Cases with Late Stage :

Missouri²

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.5 to 3.9 and 272 average annual cases over 2018-2022.
• CI*Rank ⋔ : 20 (9, 29)
• Percent of Cases with Late Stage :

Nebraska²

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.3 to 4.1 and 82 average annual cases over 2018-2022.
• CI*Rank ⋔ : 21 (5, 36)
• Percent of Cases with Late Stage :

Colorado²

• Rate : The incidence rate is 3.7 with a 95% confidence interval from 3.5 to 3.9 and 234 average annual cases over 2018-2022.
• CI*Rank ⋔ : 22 (10, 31)
• Percent of Cases with Late Stage :

Kansas²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.3 to 3.9 and 120 average annual cases over 2018-2022.
• CI*Rank ⋔ : 23 (9, 35)
• Percent of Cases with Late Stage :

Minnesota²

• Rate : The incidence rate is 3.6 with a 95% confidence interval from 3.4 to 3.8 and 234 average annual cases over 2018-2022.
• CI*Rank ⋔ : 24 (13, 33)
• Percent of Cases with Late Stage :

Michigan²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.3 to 3.7 and 431 average annual cases over 2018-2022.
• CI*Rank ⋔ : 25 (17, 33)
• Percent of Cases with Late Stage :

Rhode Island²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.1 to 4.0 and 49 average annual cases over 2018-2022.
• CI*Rank ⋔ : 26 (7, 44)
• Percent of Cases with Late Stage :

Pennsylvania²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.4 to 3.6 and 593 average annual cases over 2018-2022.
• CI*Rank ⋔ : 27 (18, 32)
• Percent of Cases with Late Stage :

Arkansas²

• Rate : The incidence rate is 3.5 with a 95% confidence interval from 3.2 to 3.8 and 127 average annual cases over 2018-2022.
• CI*Rank ⋔ : 28 (12, 38)
• Percent of Cases with Late Stage :

South Carolina²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.2 to 3.6 and 218 average annual cases over 2018-2022.
• CI*Rank ⋔ : 29 (17, 37)
• Percent of Cases with Late Stage :

North Carolina²

• Rate : The incidence rate is 3.4 with a 95% confidence interval from 3.3 to 3.6 and 425 average annual cases over 2018-2022.
• CI*Rank ⋔ : 30 (20, 35)
• Percent of Cases with Late Stage :

Mississippi²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.0 to 3.6 and 111 average annual cases over 2018-2022.
• CI*Rank ⋔ : 31 (18, 43)
• Percent of Cases with Late Stage :

Alabama²

• Rate : The incidence rate is 3.3 with a 95% confidence interval from 3.0 to 3.5 and 199 average annual cases over 2018-2022.
• CI*Rank ⋔ : 32 (22, 41)
• Percent of Cases with Late Stage :

Washington¹

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.1 to 3.4 and 286 average annual cases over 2018-2022.
• CI*Rank ⋔ : 33 (25, 40)
• Percent of Cases with Late Stage :

Virginia²

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.1 to 3.4 and 324 average annual cases over 2018-2022.
• CI*Rank ⋔ : 34 (26, 40)
• Percent of Cases with Late Stage :

Illinois⁷

• Rate : The incidence rate is 3.2 with a 95% confidence interval from 3.0 to 3.3 and 480 average annual cases over 2018-2022.
• CI*Rank ⋔ : 35 (28, 41)
• Percent of Cases with Late Stage :

Connecticut⁷

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.4 and 143 average annual cases over 2018-2022.
• CI*Rank ⋔ : 36 (26, 45)
• Percent of Cases with Late Stage :

Oregon²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.3 and 161 average annual cases over 2018-2022.
• CI*Rank ⋔ : 37 (28, 46)
• Percent of Cases with Late Stage :

Massachusetts²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.3 and 272 average annual cases over 2018-2022.
• CI*Rank ⋔ : 38 (30, 44)
• Percent of Cases with Late Stage :

Arizona²

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.2 and 276 average annual cases over 2018-2022.
• CI*Rank ⋔ : 39 (30, 44)
• Percent of Cases with Late Stage :

Georgia⁷

• Rate : The incidence rate is 3.1 with a 95% confidence interval from 2.9 to 3.2 and 356 average annual cases over 2018-2022.
• CI*Rank ⋔ : 40 (31, 44)
• Percent of Cases with Late Stage :

California⁷

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.8 to 3.0 and 1,293 average annual cases over 2018-2022.
• CI*Rank ⋔ : 41 (38, 45)
• Percent of Cases with Late Stage :

Texas⁷

• Rate : The incidence rate is 2.9 with a 95% confidence interval from 2.8 to 3.0 and 845 average annual cases over 2018-2022.
• CI*Rank ⋔ : 42 (39, 46)
• Percent of Cases with Late Stage :

Louisiana⁷

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.6 to 3.0 and 149 average annual cases over 2018-2022.
• CI*Rank ⋔ : 43 (36, 50)
• Percent of Cases with Late Stage :

New Mexico⁷

• Rate : The incidence rate is 2.8 with a 95% confidence interval from 2.5 to 3.1 and 75 average annual cases over 2018-2022.
• CI*Rank ⋔ : 44 (32, 50)
• Percent of Cases with Late Stage :

Nevada²

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.5 to 3.0 and 99 average annual cases over 2018-2022.
• CI*Rank ⋔ : 45 (37, 50)
• Percent of Cases with Late Stage :

Hawaii⁷

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.4 to 3.1 and 51 average annual cases over 2018-2022.
• CI*Rank ⋔ : 46 (31, 50)
• Percent of Cases with Late Stage :

New Jersey⁷

• Rate : The incidence rate is 2.7 with a 95% confidence interval from 2.6 to 2.8 and 311 average annual cases over 2018-2022.
• CI*Rank ⋔ : 47 (41, 50)
• Percent of Cases with Late Stage :

Maryland²

• Rate : The incidence rate is 2.6 with a 95% confidence interval from 2.4 to 2.8 and 190 average annual cases over 2018-2022.
• CI*Rank ⋔ : 48 (43, 50)
• Percent of Cases with Late Stage :

New York⁷

• Rate : The incidence rate is 2.5 with a 95% confidence interval from 2.5 to 2.6 and 629 average annual cases over 2018-2022.
• CI*Rank ⋔ : 49 (45, 50)
• Percent of Cases with Late Stage :

Alaska²

• Rate : The incidence rate is 2.3 with a 95% confidence interval from 1.8 to 2.9 and 18 average annual cases over 2018-2022.
• CI*Rank ⋔ : 50 (36, 51)
• Percent of Cases with Late Stage :

District of Columbia²

• Rate : The incidence rate is 1.5 with a 95% confidence interval from 1.1 to 2.0 and 10 average annual cases over 2018-2022.
• CI*Rank ⋔ : 51 (50, 51)
• Percent of Cases with Late Stage :

Puerto Rico²

• Rate : The incidence rate is 0.6 with a 95% confidence interval from 0.5 to 0.7 and 30 average annual cases over 2018-2022.
• CI*Rank ⋔ : N/A
• Percent of Cases with Late Stage :

Notes:
Created by statecancerprofiles.cancer.gov on 03/23/2026 6:47 am.

State Cancer Registries may provide more current or more local data.

† Incidence rates (cases per 100,000 population per year) are age-adjusted to the 2000 US standard population (SEER areas use 20 age groups and NPCR areas use 19 age groups). Rates are for invasive cancer only (except for bladder cancer which is invasive and in situ) or unless otherwise specified. Rates calculated using SEER*Stat. Population counts for denominators are based on Census populations as modified by NCI. The US Population Data File is used for SEER and NPCR incidence rates.

Rates are computed using cancers classified as malignant based on ICD-O-3. For more information see malignant.html.

^ Late Stage is defined as cases determined to be regional or distant. Due to changes in stage coding, Combined Summary Stage with Expanded Regional Codes (2004+) is used for data from Surveillance, Epidemiology, and End Results (SEER) databases and Merged Summary Stage is used for data from National Program of Cancer Registries databases. Due to the increased complexity with staging, other staging variables maybe used if necessary.

Source: SEER and NPCR data. For more specific information please see the table.

Data for United States does not include Puerto Rico.